OrSense's NBM 200MP non-invasive Hb measurement system more accurate than invasive POC devices

NewsGuard 100/100 Score

OrSense Ltd., developer of monitors for non-invasive measurements of various blood parameters, presented in an oral presentation at the American Society of Anesthesiologists (ASA) annual meeting in San Diego, results showing that hemoglobin (Hb) measurements obtained by its NBM 200MP, a non-invasive Hb measurement system, showed accurate performance during hemorrhage conditions compared with invasive point of care (POC) devices.

Monitoring of Hb is essential for the detection of anemia and hemorrhage, and is widely used in the ICU, ER, operating and delivery rooms. The current measurement methods are invasive, painful, time consuming and labor intensive, and are inadequate for continuous Hb monitoring, often necessary during emergency situations. Non-invasive measurement of Hb has many advantages including the prevention of pain and potential transmission of infectious diseases, the reduced need for trained personnel and the freedom to take multiple measurements continuously. NBM 200MP offers a unique, breakthrough, non-invasive solution for accurate and quick Hb measurements.

Another study, presented as a poster in the same ASA conference, validated the performance of the non-invasive NBM 200MP for continual, safe and reliable monitoring of oxygen saturation levels, even in extreme cases of low perfusion and weak pulsation, when standard pulse oximeters fail. Thus, the NBM 200MP occlusion-based oximetry may overcome the limitations of pulse oximetry, and improve the ability to detect hypoxemia and related events in ICU, OR and other hospital units. The NBM 200MP oximetry monitor is FDA cleared.

Lior Maayan, CEO of OrSense, said, "The study presented at the ASA meeting substantiates the potential of the non-invasive NBM 200MP for accurate, continual, safe, and easy-to-use monitoring of Hb, in particular under technological-challenging, potentially life-threatening conditions such as hemorrhage. We anticipate that the NBM 200MP will constitute a significant contribution to a safe and efficient critical care patient treatment."

Source:

OrSense Ltd.,

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Spicing up diabetes management: Mediterranean diet's aromatic herbs lower blood sugar